Inc. and Nanosys Inc. today announced that Evolved Machines has entered
into a sublicense agreement with Nanosys for a portfolio of patents and patent
applications related to the use of nanotubes and nanowires for artificial olfaction
and chemical sensing.
The core intellectual property involves a wide range of applications in nanotechnology,
nanomaterials and the use of nanotube and nanowire-based field effect transistors
(FET's) as biosensors. Nanosys owns an extensive portfolio of IP around multiple
aspects of nanotechnology including basic nanowire compositions, nanowire synthesis
and the use of nanowires and other nanostructures for many applications.
Under terms of the agreement, Evolved Machines has secured or has obtained
options to secure a variety of exclusive, worldwide rights among which are
the use of DNA-functionalized nanowire or nanotube-based sensor arrays for
the detection and/or identification of an analyte or analytes in the gas
and/or liquid phase.
Evolved Machines, in partnership with its affiliate iSense, LLC, is
developing nanotube-based field effect transistors (FETS) functionalized by
DNA as highly sensitive sensors across a very wide range of targets. "The
DNA sequence-dependent nature of binding affinity for these devices enables
highly diverse analyte discrimination, while the nanotube transistor imparts
great sensitivity. Further, this class of sensor is completely reversible
across a wide range of analytes, allowing repeated use and enabling the
first devices capable of remote autonomous multi-analyte sensing," according
to Dr. Paul A. Rhodes, Evolved Machines CEO.
Working in partnership with its affiliate, iSense, Evolved Machines is
developing a wide range of immediate high-value applications ranging from
airport, port and transit screening, to first responder domestic and
military hand-held sets, to medical diagnosis, to autonomous 24/7 monitoring
of the water supply and of containers on-board ship.